THC (tetrahydrocannabinol) and CBD (cannabidiol) are two naturally occurring cannabinoids found in the cannabis plant. While both cannabinoids interact with the body's endocannabinoid system, they have different characteristics and may be considered by healthcare practitioners in different clinical circumstances.
Understanding these differences can help patients have more informed discussions with healthcare professionals about medicinal cannabis treatment options.
THC is one of the primary cannabinoids found in cannabis plants. It is commonly associated with psychoactive effects and is included in various medicinal cannabis products prescribed under Australian regulations.
Healthcare practitioners may consider THC-containing products based on:
Individual patient circumstances
Treatment objectives
Medical history
Previous treatment experiences
Because THC may affect individuals differently, healthcare professionals carefully assess whether THC-containing products may be appropriate.
Patients seeking broader information may wish to read:
CBD is another naturally occurring cannabinoid found in cannabis plants. Unlike THC, CBD is generally not associated with intoxicating effects.
CBD-containing medicinal cannabis products are available in a range of formulations and concentrations depending on clinical requirements and regulatory pathways.
Healthcare practitioners consider multiple factors before recommending any medicinal cannabis product, including products containing CBD.
Medicinal cannabis products may contain:
THC only
CBD only
Balanced THC and CBD combinations
Various cannabinoid ratios
The selection of any product formulation remains a clinical decision made by an appropriately qualified healthcare practitioner.
Further information about product categories is available through:
Medicinal cannabis treatment should always occur under appropriate medical supervision.
Healthcare practitioners can assist patients in understanding:
Potential risks and considerations
Product categories
Administration methods
Monitoring and follow-up requirements
Patients interested in cannabinoid research and medicinal cannabis education may also explore: